you bring up a great point - what should people be doing

New Post Public Reply Private Reply Replies (0) Message Board
Hulk767 MIM-104 #138724
683
you bring up a great point - what should people be doing right now? Based on volume, no one has been doing much of anything. because even on days we hit 1mm in volume - that's still only $160K of volume across the entire market, given how low the SP is - almost nothing.

I've averaged down over the past couple years - but finally hit a point where i had paused - because the combination of silence, no CEO, etc. left me wondering what was going on, and if i was throwing good money after bad. i just didn't have the confidence to keep pouring money in, and when my friends asked what the *$%# was going to happen with CytoDyn, i would just say "i really don't know" - and based on the lack of buying, volume, etc, that apathy had clearly gotten widespread.

i do feel a little different here. while i'm not sounding the "all clear" based just on that letter, as we still have to get the hold lifted, and we still have to hire a CEO - i do feel better about those things happening - ideally in the next month or so.

That leaves us at the current juncture. The market cap of this company is less than $150MM right now - which is truly unbelievable. At that valuation, the market is discounting that it pretty much will never generate any revenue. If you think we do get the hold lifted, we do get a CEO, and we attract a partner to fund a trial for any indication (even a smaller indication - portion of the HIV market, etc) - the value / SP should climb substantially. my point is that even hitting a single or double on the business front at this point will likely represent a home run for investors - a large multiple on the current SP.

For me, my plan is this. I'm not buying shares tomorrow. but, if we get the hold lifted and hire a CEO, i'll add shares - even if the SP doubles on those announcements. that might sound dumb - but i have a lot of exposure already, and those milestones will de-risk the go forward to some extent. and even at 30 cents or 50 cents, the stock will be extremely cheap relative to even a very conservative future value. But.....for someone who wants maximum upside potential (and is willing to place his family jewels on the line), this very moment could very well be the point of maximum opportunity.




CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 70

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
AptarGroup Faces Investigation: Shareholder Stakes High

Updated Category News Views 89

AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...

Continue Reading
24X Partners with Standard Chartered for Crypto Leap

Updated Category News Views 86

24X Steps Up the Game with Crypto Addition You gotta give it to 24X—they're not just twiddling their thumbs in the background. These folks in Bermuda have snagged another feather in their cap by expanding their partnership with heavyweight Standard Chartered, bringing Bitcoin and Ethereum into the mix. We're talking big moves here as 24X becomes the first to offer...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 191

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Sino Biological Boosts AI Protein Discovery Efficiency

Updated Category News Views 37

Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...

Continue Reading
VT Markets Unites Trading and Drama in New Finale

Updated Category News Views 76

Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...

Continue Reading
Poland's Economic Boom: A Case for Freedom and Growth

Updated Category News Views 60

Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 81

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
AION Labs Elevates Leadership, Eyes New R&D Horizons

Updated Category News Views 70

Setting New Standards in Pharma Innovation The air in Rehovot, Israel might be filled with more than just technological aspirations, thanks to AION Labs stepping up its leadership game. This venture studio doesn't seem content to rest on its laurels. Nope, it's diving headlong into the deeper end of pharma R&D, scouting out fresh tech territories like quantum computing...

Continue Reading
1-800Accountant Secures Global Win in Tax Services

Updated Category News Views 53

Another Feather in the Cap for 1-800Accountant You don’t get to be at the top of your game without turning a few heads. And 1-800Accountant has done just that, snagging the Fall 2026 Clutch Global Award for their expertise in the accounting universe. The Importance of Listening In this day and age, businesses large and small are realizing that the voice of the client is...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Fundraising Campaign to Restore Food Bank Services

Updated Category News Views 160

Transforming Community Support Through Art and Action In the wake of devastating wildfires that impacted a significant area, a new initiative is taking shape to assist those affected. This unique campaign combines the power of art and activism to address an urgent community need: the restoration of a food bank that has served countless families over the past two decades....

Continue Reading
OYO Expands Horizons with Acquisition of G6 Hospitality

Updated Category News Views 67

OYO Acquires G6 Hospitality: A Major Strategic Move In a significant development, Oravel Stays, the parent company of OYO, has announced its acquisition of G6 Hospitality from Blackstone Real Estate for $525 million. This all-cash deal aims to strengthen OYO's presence in the U.S. hospitality industry. Growing Presence in the United States Since diving into the U.S....

Continue Reading
Dizal's Sunvozertinib Receives FDA Priority Review for NSCLC

Updated Category News Views 262

FDA's Priority Review of Sunvozertinib: A Game Changer for NSCLC Dizal is making headlines with the announcement that the U.S. Food and Drug Administration (FDA) has granted priority review for the company's New Drug Application (NDA) for Sunvozertinib. This oral EGFR inhibitor holds the promise of offering a significant treatment option for patients suffering from...

Continue Reading
Deep Dive into Masimo Corporation's Ongoing Legal Troubles

Updated Category News Views 294

Masimo Corporation Under Scrutiny Recently, the spotlight has turned to Masimo Corporation (NASDAQ: MASI) as investigations unfold regarding potential misconduct among its leadership. The inquiry is spearheaded by Charles C. Foti, Jr., a former Attorney General of Louisiana and partner at Kahn Swick & Foti, LLC. Revenue Shortfalls and Investor Concerns The company faced a...

Continue Reading
PMV Pharmaceuticals Unveils Promising Monotherapy Data for Solid Tumors

Updated Category News Views 471

Exciting Developments in Cancer Treatment In the realm of precision oncology, PMV Pharmaceuticals continues to lead the charge with groundbreaking research that shines a spotlight on novel therapies. Today, the company has presented updated interim data that promises to reshape the treatment landscape for patients dealing with advanced solid tumors, particularly those...

Continue Reading